Monitoring phosphorylation of the pyruvate dehydrogenase complex
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The pyruvate dehydrogenase multienzyme complex (PDC) is a key regulatory point in cellular metabolism linking glycolysis to the citric acid cycle and lipogenesis. Reversible phosphorylation of the pyruvate dehydrogenase enzyme is a critical regulatory mechanism and an important point for monitoring metabolic activity. To directly determine the regulation of the PDC by phosphorylation, we developed a complete set of phospho-antibodies against the three known phosphorylation sites on the E1 alpha subunit of pyruvate dehydrogenase (PDHE1α). We demonstrate phospho-site specificity of each antibody in a variety of cultured cells and tissue extracts. In addition, we show sensitivity of these antibodies to PDH activity using the pyruvate dehydrogenase kinase specific inhibitor dichloroacetate. We go on to utilize these antibodies to assess PDH phosphorylation in a patient suffering from Leigh's Syndrome. Finally, we observed changes in individual phosphorylation states following a small molecule screen, demonstrating that these reagents should be useful for monitoring phosphorylation of PDHE1α and, therefore, overall metabolism in both the disease state as well as in response to a myriad of physiological and pharmacological stimuli.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Role of dichloroacetate in the treatment of genetic mitochondrial diseases
Stacpoole, P. W., Kurtz, T. L., Han, Z., & Langaee, T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.02.014 · Cited by 145 · cited 1×
“DCA is a pyruvate analog currently under investigation for use in the treatment of genetic mitochondrial diseases, as well as cancer, for its ability to reverse the Warburg effect by shifting metabolism from glycolysis back to glucose oxidation [27;28].”
Method
Cited by
AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function
Dugan, L. L., You, Y.-H., Ali, S. S., Diamond-Stanic, M., Miyamoto, S., DeCleves, A.-E., Andreyev, A., Quach, T., Ly, S., Shekhtman, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66218 · Cited by 456
Self-citationSchilling, B., Rardin, M. J., MacLean, B. X., Zawadzka, A. M., Frewen, B. E., Cusack, M. P., Sorensen, D. J., Bereman, M. S., Jing, E., Wu, C. C., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.017707 · Cited by 449
Self-citationSirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity
Mathias, R. A., Greco, T. M., Oberstein, A., Budayeva, H. G., Chakrabarti, R., Rowland, E. A., Kang, Y., Shenk, T., & Cristea, I. M. (2014) · Cell · doi:10.1016/j.cell.2014.11.046 · Cited by 430
“…(Jackson Laboratory, Stock number 012756), and control (WT) (Jackson Laboratory, Stock number 002448) adult female mice (n = 4) were euthanized, livers excised, and mitochondria isolated as previously described (Rardin et al., 2009) with modifications detailed in Extended Experimental Procedures.”
MethodMitochondrial calcium exchange in physiology and disease
Garbincius, J. F., & Elrod, J. W. (2022) · Physiological Reviews · doi:10.1152/physrev.00041.2020 · Cited by 412
Mitochondrial Pathology and Glycolytic Shift during Proximal Tubule Atrophy after Ischemic AKI
Lan, R., Geng, H., Singha, P. K., Saikumar, P., Bottinger, E. P., Weinberg, J. M., & Venkatachalam, M. A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015020177 · Cited by 353
Metadata
- Authors
- Rardin, M. J., Wiley, S. E., Naviaux, R. K., Murphy, A. N., & Dixon, J. E.
- Venue
- Analytical Biochemistry
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 389
- Issue
- 2
- Pages
- 157-164
- ISSN
- 0003-2697 (ISSN-L)
- OpenAlex
- W2000697370
- Cited by
- 152
- References
- 2
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.